Effect of Trigonella foenum-graecum L. on Metabolic Activity of CYP2D6 and CYP3A4

Publisher： Karger

E-ISSN： 1661-4127|22|3|180-184

ISSN： 1661-4119

Source： Forschende Komplementärmedizin / Research in Complementary Medicine, Vol.22, Iss.3, 2015-06, pp. : 180-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1122-1130

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics of Codeine, Morphine, and Morphine-6-Glucuronide: Model-Based Analysis of the Influence of CYP2D6 Activity, UGT2B7 Activity, Renal Impairment, and CYP3A4 Inhibition

By Eissing Thomas   Lippert Jörg   Willmann Stefan  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 1, 2012-02 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 5, 2015-05 ,pp. : 785-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

CYP2D6 Genotype and Adjuvant Tamoxifen

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 138-140

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications

By Albuquerque José   Ribeiro Carolina   Naranjo Maria Eugenia G   Llerena Adrián   Grazina Manuela  

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 709-718

Future Medicine

Access to resources Recommend Favorite